<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The most important complication of <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> (AF) is <z:hpo ids='HP_0001727'>thromboembolic stroke</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Although AF-related remodeling is considered important in atrial thrombogenesis, its role never has been directly tested </plain></SENT>
<SENT sid="2" pm="."><plain>This study assessed effects of AF-related remodeling on the atrial thrombogenic milieu by using radiofrequency ablation (RFA) to create a quantifiable prothrombotic nidus </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS AND RESULTS: We studied <z:mpath ids='MPATH_458'>normal</z:mpath> control dogs (control, n=16) and 3 canine AF-models: (1) atrial <z:hpo ids='HP_0001649'>tachycardia</z:hpo> remodeling (ATR; n=16) induced by atrial tachypacing (400 bpm for 1 week, with <z:hpo ids='HP_0001678'>atrioventricular block</z:hpo> and ventricular pacing at 80 bpm); (2) <z:hpo ids='HP_0001635'>congestive heart failure</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CHF</z:e>; n=14) attributable to ventricular tachypacing (240 bpm for 2 weeks); and (3) <z:hpo ids='HP_0011010'>chronic</z:hpo> AF (CAF; n=8) induced by atrial tachypacing (35±3 days) without <z:hpo ids='HP_0001678'>atrioventricular block</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>CAF dogs had AF for 13±1 days until euthanization </plain></SENT>
<SENT sid="5" pm="."><plain>After remodeling was established, RFA lesions were created in both atria </plain></SENT>
<SENT sid="6" pm="."><plain>Half the ATR and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CHF</z:e> dogs were subjected to atrial tachypacing during 7-day post-RFA follow-up </plain></SENT>
<SENT sid="7" pm="."><plain>Electrophysiological and echocardiographic studies were performed before RFA and 7 days after RFA, and then hearts were removed and atrial <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> were quantified by histomorphometry </plain></SENT>
<SENT sid="8" pm="."><plain>Burst-pacing-induced AF duration was significantly greater in ATR, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CHF</z:e>, and CAF groups versus control group </plain></SENT>
<SENT sid="9" pm="."><plain>The atrial effective refractory period shortened in ATR and CAF groups </plain></SENT>
<SENT sid="10" pm="."><plain>Left atrial diameter was significantly larger with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CHF</z:e>, but not with ATR </plain></SENT>
<SENT sid="11" pm="."><plain>Neither total <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> volume nor <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> volume per lesion differed significantly among groups </plain></SENT>
<SENT sid="12" pm="."><plain>Table.Properties of Ablation Lesions and Atrial <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">Thrombi</z:e> Experimental GroupControl (n=16)ATR (n=16)<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CHF</z:e> (n=14)CAF (n=8)N of ablation lesions per dog6.9±0.36.6±0.27.2±0.26.9±0.4Ablation lesion area, mm(2)53.1±3.558.3±4.857.7±4.944.3±3.7Ablation lesion depth, mm5.2±0.25.1±0.35.3±0.25.2±0.2Ablation lesion volume, mm(3)205.2±17.8211.6±17.6231.5±29.0176.8±22.2N of <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> per dog5.4±0.44.7±0.35.6±0.46.5±0.4Presence of <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e>, %80±572±577±695±3Mean <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> volume in both atria, mm(3)20.8±3.414.9±2.212.2±2.622.5±5.6Mean <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> volume in left atria, mm(3)8.2±1.54.0±0.95.5±1.68.1±3.3Mean <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> volume in right atria, mm(3)30.1±5.422.7±4.317.9±4.132.8±8.3Total <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> volume in both atria, mm(3)140.5±21.399.7±16.886.1±17.5131.1±22.7Total <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> volume in left atria, mm(3)22.8±5.311.8±3.317.0±3.723.3±6.4Total <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> volume in right atria, mm(3)117.7±21.587.8±17.269.1±16.1107.8±23.3Thrombus volume normalized to ablation lesion area in both atria, mm(3)/mm(2)0.5±0.10.4±0.11.5±1.10.8±0.3Thrombus volume normalized to ablation lesion volume in both atria0.2±0.10.1±0.00.5±0.40.3±0.1 ATR indicates atrial <z:hpo ids='HP_0001649'>tachycardia</z:hpo> remodeling; CAF, <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo>; and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CHF</z:e>, <z:hpo ids='HP_0001635'>congestive heart failure</z:hpo> </plain></SENT>
<SENT sid="13" pm="."><plain>There were no statistically significant differences for any groups vs control group for any of these variables studied </plain></SENT>
<SENT sid="14" pm="."><plain>CONCLUSIONS: None of the AF substrates tested, including sustained atrial <z:hpo ids='HP_0001649'>tachycardia</z:hpo>/AF itself, enhanced post-RFA atrial <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation </plain></SENT>
<SENT sid="15" pm="."><plain>Indices of electrical and structural remodeling did not predict post-RFA thrombogenic potential </plain></SENT>
<SENT sid="16" pm="."><plain>Contrary to widely held but previously untested notions, we were unable to demonstrate prothrombotic effects of AF-related remodeling </plain></SENT>
</text></document>